However, a recent review pointed out that SGLT2 inhibitors have been shown to decrease hepcidin and ferritin and increase transferrin receptor protein, which is suggestive of worsening iron deficiency [91]. The gene discussed is SLC5A2; the disease is Iron deficiency anemia.